Epic (tetracaine spray)
/ Futura Medical
- LARVOL DELTA
Home
Next
Prev
1 to 3
Of
3
Go to page
1
July 06, 2020
[VIRTUAL] Pulmonary Blood Flow Assessed by 15O-Water PET in Healthy Subjects and Patients with Pulmonary Hypertension
(ATS-I 2020)
- "Methods : 15O-water PET(500 MBq, dynamic scan for 6 minutes) was performed at rest and after exercise of ergometer at anaerobic metabolism threshold for 5 minutes in supine position...C onclusions : This preliminary study suggested that time to peak of 15O-water was significantly longer and more heterogeneous in the lungs in patients with CTEPH, compared with healthy subjects. 15O-H2O PET might be of potential use for the early detection of altered blood flow in the lung and repeatable evaluation of therapeutic intervention in pulmonary vascular diseases."
Clinical • Hypertension • Pulmonary Arterial Hypertension
March 15, 2020
Pulmonary Blood Flow Assessed by 15O-Water PET in Healthy Subjects and Patients with Pulmonary Hypertension
(ATS 2020)
- "Thus, quantitative assessment of pulmonary blood flow by 15O-water positron emission tomography(PET) may improve the diagnostic precision and the management of pulmonary vascular diseases.Objectives: We aimed to evaluate time to peak of 15O-H2O, at rest and after exercise assessed by PET between healthy subjects and patients with pulmonary hypertension. 15O-water PET(500 MBq, dynamic scan for 6 minutes) was performed at rest and after exercise of ergometer at anaerobic metabolism threshold for 5 minutes in supine position... This preliminary study suggested that time to peak of 15O-water was significantly longer and more heterogeneous in the lungs in patients with CTEPH, compared with healthy subjects. 15O-H2O PET might be of potential use for the early detection of altered blood flow in the lung and repeatable evaluation of therapeutic intervention in pulmonary vascular diseases."
Clinical
January 30, 2020
FM48: Study to Determine the Effect of a Newly Formulated Tetracaine Product PET500 on Penile Skin Sensation
(clinicaltrials.gov)
- P1; N=20; Completed; Sponsor: Futura Medical Developments Ltd.
New P1 trial
1 to 3
Of
3
Go to page
1